Regenimo Biosciences
Houston, US · Founded 2025 · Delaware corporation
Founders & leadership
SS
Sharon ShachamNamed on SEC filing
Board
LC
Lynda ChinBoard director
RK
Raju KucherlapatiBoard director
Reported raises · per SEC filings
Form D private placements$2M disclosed across 1 round · 2025
▶$2MraisedNov 2025 · 6 investors · BiotechnologyRule 506(b)
▶$2MraisedNov 2025 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sharon ShachamExecutive Officer, Director
- Lynda ChinDirector
- Raju KucherlapatiDirector
- Offering amount
- $2M
- Amount sold
- $2M
- Minimum investment
- $50K
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Regenimo Biosciences raised?
- Regenimo Biosciences has disclosed $2M raised across 1 round.
- Where is Regenimo Biosciences headquartered?
- Regenimo Biosciences is headquartered in Houston, US.